I H Tuzel. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, OralAdultAgingAnesthesiaAngiographyAntihypertensive Agents/administration & dosageAntihypertensive Agents/adverse effectsAntihypertensive Agents/therapeutic useChemical PhenomenaChemistryChildFerricyanides/administration & dosageFerricyanides/adverse effectsFerricyanides/therapeutic useFerricyanides/toxicityHeart Failure/drug therapyHumansHypertension/drug therapyInjections, IntravenousKidney Diseases/diagnosisMyocardial Infarction/drug therapyNitric Oxide/administration & dosageNitric Oxide/adverse effectsNitric Oxide/therapeutic useNitric Oxide/toxicityRenin/metabolismTachyphylaxis/drug effectsVascular Resistance/drug effectsVasodilator Agents/pharmacology
Substances: See more » Antihypertensive AgentsFerricyanidesVasodilator AgentsNitric OxideRenin
Year: 1974 PMID: 4610012 DOI: 10.1002/j.1552-4604.1974.tb01363.x
Source DB: PubMed Journal: J Clin Pharmacol ISSN: 0091-2700 Impact factor: 3.126